.jpg)
.png)
Top Stories
On January 29, the U.S. FDA approved mipomersen sodium injection as an adjunct to treat LDL-C, Apo B, total cholesterol, and non HDL-C in patients with homozygous familial hypercholesterolemia (HoFH). Mipomersen, known by the brand name Kynamro, will be marketed in the U.S. by Genzyme, a Sanofi... more
The new ICD-10 Codes were released by the Center for Medicare & Medicaid Services (CMS). Two new specific codes for FH have been approved: E78.01: Familial hypercholesterolemia Z83.42: Family history of familial hypercholesterolemia The National Lipid Association (NLA) in... more
On April 23, Amarin Corp. issued a press release announcing that the U.S. FDA has accepted its Supplemental New Drug Application (sNDA) seeking approval for the marketing and sale of Vascepa (icosapent ethyl) capsules for use as an adjunct to diet in the treatment of adult patients with high... more
Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous... more
For heart health, you're supposed to know your numbers: total cholesterol, the bad LDL kind and the good HDL kind. Associated Press - November 7, 2011
On Friday, May 3, the U.S. FDA approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough. For more information, please... more
The window for nominations to NLA and Chapter leadership positions is now open through February 28, 2021. Open positions include: National Lipid Association positions include: At-Large Board Member (up to 7) Chapter positions include: President-Elect Treasurer... more
All U.S. children between the ages of 9 and 11 should be screened for high cholesterol, according to new guidelines endorsed by the nation's leading group of pediatricians. U.S. News & World Report - November 11, 2011
The National Lipid Association (NLA) has named Matthew Ito, PharmD (’86), as its new president. Membership of the NLA includes physicians, pharmacists, researchers, nurses, physician assistants and dietitians. USC School of Pharmacy News – June 2013
Responses from healthcare workers show significant barriers to prescriptions PCSK9 Inhibitors Survey Findings Infographic Download PCSK9 Inhibitors Approval Checklist Download JACKSONVILLE, Fla. — The National Lipid Association (NLA) released on Wednesday the results of its survey on... more